Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine for recovery and cognitive function after thoracoscopic surgery
ChiCTR2200063878Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lung neoplasm comparing Remimazolam group with Dexmedetomidine group (2 arms). Primary endpoints: Ricker sedation-agitation score, Steward score and 2 more. Started Sep 2022; status: recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
lung neoplasm
Beyond the preview
Go deeper on ChiCTR2200063878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063878.